![Lysosomal storage diseases / Glycogen storage disease type II / Hepatology / Alglucosidase alfa / Enzyme replacement therapy / ERT / Amyotrophic lateral sclerosis / Immunogenicity / Medicine / Health / Rare diseases Lysosomal storage diseases / Glycogen storage disease type II / Hepatology / Alglucosidase alfa / Enzyme replacement therapy / ERT / Amyotrophic lateral sclerosis / Immunogenicity / Medicine / Health / Rare diseases](https://www.pdfsearch.io/img/f08e6213fa18bc4dd5cd6ebfb91a2d82.jpg) Date: 2012-11-15 18:10:29Lysosomal storage diseases Glycogen storage disease type II Hepatology Alglucosidase alfa Enzyme replacement therapy ERT Amyotrophic lateral sclerosis Immunogenicity Medicine Health Rare diseases | | October 11, 2012 Amicus Therapeutics Announces Positive Pompe Program Updates AT2220-Enzyme Replacement Therapy (ERT) Co-Administration Increases Pompe Enzyme (rhGAA) Activity in First 3 Dose Cohorts in Phase 2 Study ATAdd to Reading ListSource URL: www.unitedpompe.comDownload Document from Source Website File Size: 103,46 KBShare Document on Facebook
|